| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.007 |